Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Wisner Baum Investigates Syngenta Amid Renewed Questions Over Atrazine Safety


News provided by

Wisner Baum

May 12, 2026, 12:02 ET

Share this article

Share toX

Share this article

Share toX

Mounting scientific evidence is raising serious concerns that long-term exposure to atrazine, one of the most widely used herbicides in the United States, may contribute to the development of non-Hodgkin lymphoma. Wisner Baum attorneys investigating potential claims say farmworkers, pesticide applicators, and rural families may have been exposed for decades without adequate safety warnings.

LOS ANGELES, May 12, 2026 /PRNewswire/ -- A growing body of scientific research is intensifying scrutiny of atrazine, one of the most commonly used herbicides in American agriculture, over its potential connection to non-Hodgkin lymphoma (NHL) and other types of cancer.

Continue Reading
“Many of the people potentially affected spent years working to feed the country and may never have realized the dangers they were being exposed to. As more research emerges linking atrazine to non-Hodgkin lymphoma, families deserve answers about whether these risks were known and adequately disclosed.” - Pedram Esfandiary, partner and trial attorney at Wisner Baum
“Many of the people potentially affected spent years working to feed the country and may never have realized the dangers they were being exposed to. As more research emerges linking atrazine to non-Hodgkin lymphoma, families deserve answers about whether these risks were known and adequately disclosed.” - Pedram Esfandiary, partner and trial attorney at Wisner Baum

At least 60 countries have banned atrazine, according to Health Policy Watch. Timothy A. Loranger, attorney and senior partner at Wisner Baum, a nationally recognized plaintiffs' law firm that represents farmers, pesticide applicators, landscapers, and others, said, "Atrazine is much more strictly regulated in the European Union. It was banned in 2004 when regulators determined the chemical's groundwater contamination was ubiquitous and unpreventable. Despite international restrictions, atrazine remains readily available in the U.S."

Used extensively on corn and soybean crops across the Midwest and other farming regions, atrazine has long been detected in groundwater, surface water, and private wells near agricultural communities. Recent epidemiological and laboratory studies have raised concerns that chronic exposure may cause endocrine disruption, oxidative stress, inflammation, and immune system effects associated with the development of cancer such as NHL—particularly among farmers, pesticide applicators, and rural residents exposed over long periods of time.

"What makes atrazine especially alarming is the scale and duration of exposure," Loranger said. "This is not an isolated chemical confined to industrial settings; it has been detected in drinking water sources and agricultural communities across the country for decades."

Loranger is working with Wisner Baum's Pedram Esfandiary, partner and trial attorney, to investigate potential claims involving individuals diagnosed with NHL after prolonged occupational or environmental exposure to atrazine.

Research Points to Atrazine and Elevated Cancer Risk

A 2025 evaluation by the International Agency for Research on Cancer (IARC) classified atrazine as "probably carcinogenic to humans", noting robust evidence that the chemical demonstrates hallmark characteristics of carcinogens. The organization concluded that atrazine causes oxidative stress, induces inflammation and acts as an immunosuppressant, along with other carcinogenic properties. These findings are consistent with broader environmental monitoring data demonstrating the pervasive presence of atrazine in agricultural communities.

A 2025 University of Nebraska Medical Center study analyzed decades of environmental monitoring data—including more than 27,000 groundwater samples and 31,000 surface water observations—and identified widespread atrazine contamination in private well water samples collected across several Nebraska farming counties. In Cass County, atrazine was detected in 93.75% of sampled wells, while counties including Phelps and Clay showed contamination rates above 80%.

"For decades, atrazine has been applied on a massive scale across American farmland while questions about its long-term health effects continued to grow," Esfandiary said. "When substantial scientific evidence begins pointing to a possible connection between chronic exposure and devastating diseases like cancer, the public deserves transparency, accountability, and a full examination of what manufacturers knew about those risks."

Unlike many consumer chemical products, atrazine exposure occurs primarily through occupational and environmental contact. Farmworkers, pesticide applicators, agricultural families, and residents living near heavily farmed areas may face repeated exposure through spraying operations, contaminated water sources, and agricultural runoff.

According to the U.S. Environmental Protection Agency (EPA), approximately 72 million pounds of atrazine are applied annually in the United States, most heavily across Midwestern agricultural states. Researchers noted that the chemical is highly persistent in water and can remain stable for more than 200 days, increasing the likelihood of prolonged environmental exposure in rural communities.

Syngenta's Conduct Draws Renewed Attention

The investigation also comes amid renewed scrutiny of Syngenta, atrazine's manufacturer, following previously unsealed court documents and investigative reporting concerning the company's response to criticism of the herbicide.

According to investigative reporting published by Environmental Health News, internal records described efforts by Syngenta to challenge scientists and researchers who raised concerns about atrazine's safety, including alleged opposition research, undisclosed relationships with third-party advocates, and coordinated public relations campaigns intended to protect atrazine's market position.

The controversy stems in part from litigation involving contamination of public water systems, which resulted in a $105 million settlement related to atrazine filtration costs for more than 1,000 water systems across multiple states.

Although Syngenta denied wrongdoing and has maintained that atrazine is safe when used as directed, critics argue the records raise broader questions about transparency surrounding potential long-term health risks.

"Many of the people potentially affected spent years working to feed the country and may never have realized the dangers they were being exposed to," Esfandiary said. "As more research emerges linking atrazine to non-Hodgkin lymphoma, families deserve answers about whether these risks were known and adequately disclosed."

Investigation Focused on Non-Hodgkin Lymphoma Claims

Wisner Baum's investigation is focused on individuals who worked in agriculture, handled pesticides, or lived near heavily farmed areas and were later diagnosed with non-Hodgkin lymphoma or other types of cancer.

The firm is reviewing potential claims involving long-term atrazine exposure and whether manufacturers adequately warned the public about possible health risks.

Individuals who have been diagnosed with NHL after extensive exposure to atrazine are encouraged to seek medical evaluation and learn more about available legal options by calling Wisner Baum at (855) 687-4410.

About Wisner Baum

Wisner Baum began with a simple but radical idea: the law should serve people, not protect power. Since opening its doors in 1985, the firm has gone far beyond courtroom victories. Based in Los Angeles and known across the U.S., Wisner Baum has built its legacy by holding powerful corporations accountable, not just to win justice for individual clients, but to spark broader societal change.

Every case they take on, from catastrophic injuries and pharmaceutical failures to environmental toxicity and corporate negligence, is part of a bigger mission: to make the world safer, more just, and more transparent for everyone. With more than $4 billion in verdicts and settlements, their legal victories have helped raise public awareness, influence regulations, and force industries to clean up harmful practices. Their work has become a catalyst for product safety reforms, food transparency, and medical accountability.

Wisner Baum isn't just a law firm. It's a movement for change, where justice isn't the end goal, but the beginning of a safer society.

Wisner Baum: Changing the System for Societal Change, One Case at a Time.

Learn more at wisnerbaum.com.

Sources:

  1. Samantaroy, S. (2026, January 5). US EPA dismisses WHO cancer agency determination that widely used herbicide is probably carcinogenic. Health Policy Watch.
  2. Egbuchiem, A. (2025). Assessing the impact of atrazine and paraquat on Parkinson's disease prevalence in rural Nebraska counties (Master of Public Health capstone project, University of Nebraska Medical Center). DigitalCommons@UNMC.
  3. Cattley, R. C., De Roos, A. J., Mandrioli, D., Pearce, N., Pronk, A., Soshilov, A., et al. (2025). Carcinogenicity of atrazine, alachlor, and vinclozolin. The Lancet Oncology, 27(1). thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00702-8/fulltext
  4. Environmental Health News. (2013, June 17). Special Report: Syngenta's campaign to protect atrazine, discredit critics.
  5. U.S. Environmental Protection Agency. (2020). Atrazine: Interim registration review decision. epa.gov/ingredients-used-pesticide-products/atrazine-interim-registration-review-decision
  6. Beseler, C. L., et al. (2021). Atrazine levels in rural Nebraska counties and Parkinson's disease (MPH capstone project, University of Nebraska Medical Center). DigitalCommons@UNMC.

Media Contact:

Karla Jo Helms
JOTO PR
727-777-4629
jotopr.com

SOURCE Wisner Baum

21%

more press release views with 
Request a Demo

Modal title

Also from this source

$11.8M Verdict Against LAPD Signals Breaking Point for "Less-Lethal" Crowd-Control Tactics

$11.8M Verdict Against LAPD Signals Breaking Point for "Less-Lethal" Crowd-Control Tactics

In a decisive rebuke of police crowd-control practices, a federal jury has awarded $11.8 million to Isaac Castellanos, who was permanently blinded in ...

Bering Air Chose Profit Over Safety in Fatal Alaska Crash, Wisner Baum Lawsuit Alleges

Bering Air Chose Profit Over Safety in Fatal Alaska Crash, Wisner Baum Lawsuit Alleges

Wisner Baum LLP has filed a wrongful death lawsuit against Bering Air, Inc., alleging the airline knowingly operated an unsafe aircraft in hazardous...

More Releases From This Source

Explore

Agriculture

Agriculture

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.